Monday November 23 2009 | Biotechnology feed | All feeds
|
|
Angstrom Pharmaceuticals Incorporated
Download detailed PDF Members: Ångstrom Pharmaceuticals, Inc. was formed in 1996 to add a new dimension to drug discovery. It is committed to discovering drugs that block the docking of an extracellular regulatory protein (ligand) to its receptor found on the outside of a cell – when this event is responsible for initiating a disease state. Receptors can be identified that trigger several intractable diseases including cancer, the first focus of the Company's mission. Ångstrom targets a receptor for blockade only following a detailed analysis of that receptor’s role in the disease. The blocking drugs are designed such that they can easily reach their site of action and have minimal side effects.
This page has been viewed 286 times since April 2007, the link to the organisation's website has been followed 60 times Search for more companies in San Diego Search for more companies in CA This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Angstrom Pharmaceuticals Incorporated | |||||||||||||||||||||||||||||||||||||||||||||||
|